ProfileGDS4718 / 238517_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 36% 36% 40% 41% 35% 36% 40% 41% 37% 36% 33% 32% 36% 37% 33% 34% 38% 39% 36% 33% 38% 39% 37% 35% 37% 35% 43% 36% 33% 40% 37% 41% 37% 43% 34% 39% 39% 42% 40% 30% 40% 39% 39% 39% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8149536
GSM549102patient 115, normal, homogenized [OPG study]4.8235536
GSM549104patient 119, normal, homogenized [OPG study]4.9791540
GSM549108patient 138, normal, homogenized [OPG study]5.08741
GSM549119patient 077, normal, homogenized [OPG study]4.7782335
GSM549133patient 032, cancer, homogenized [OPG study]4.759736
GSM549139patient 042, cancer, homogenized [OPG study]4.9585640
GSM549099patient 107, normal, homogenized [OPG study]5.0411541
GSM549109patient 139, normal, homogenized [OPG study]4.8469537
GSM549110patient 046, normal, homogenized [OPG study]4.7920836
GSM549114patient 063, normal, homogenized [OPG study]4.6096233
GSM549122patient 082, normal, homogenized [OPG study]4.6183532
GSM549134patient 033, cancer, homogenized [OPG study]4.817936
GSM549136patient 036, cancer, homogenized [OPG study]4.8098737
GSM549140patient 044, cancer, homogenized [OPG study]4.6417933
GSM549111patient 047, normal, homogenized [OPG study]4.6929834
GSM549113patient 057, normal, homogenized [OPG study]4.8577838
GSM549132patient 031, cancer, homogenized [OPG study]4.9297839
GSM549137patient 038, cancer, homogenized [OPG study]4.7737236
GSM549142patient 047, cancer, homogenized [OPG study]4.7911933
GSM549100patient 110, normal, homogenized [OPG study]4.9246938
GSM549107patient 135, normal, homogenized [OPG study]4.9131139
GSM549115patient 068, normal, homogenized [OPG study]4.7817837
GSM549116patient 072, normal, homogenized [OPG study]4.7534435
GSM549120patient 078, normal, homogenized [OPG study]4.8564237
GSM549131patient 030, cancer, homogenized [OPG study]4.7177635
GSM549118patient 074, normal, homogenized [OPG study]5.1352243
GSM549129patient 027, cancer, homogenized [OPG study]4.8318936
GSM549123patient 088, normal, homogenized [OPG study]4.6499733
GSM549124patient 006, cancer, homogenized [OPG study]5.0289140
GSM549126patient 015, cancer, homogenized [OPG study]4.8533137
GSM549128patient 025, cancer, homogenized [OPG study]5.0270941
GSM549103patient 117, normal, homogenized [OPG study]4.9057337
GSM549117patient 073, normal, homogenized [OPG study]5.0896343
GSM549138patient 041, cancer, homogenized [OPG study]4.6932634
GSM549141patient 045, cancer, homogenized [OPG study]4.8610239
GSM549130patient 028, cancer, homogenized [OPG study]4.9259939
GSM549101patient 111, normal, homogenized [OPG study]5.1067342
GSM549105patient 128, normal, homogenized [OPG study]4.9947940
GSM549106patient 134, normal, homogenized [OPG study]4.4758930
GSM549112patient 048, normal, homogenized [OPG study]5.0026640
GSM549125patient 011, cancer, homogenized [OPG study]4.937939
GSM549127patient 024, cancer, homogenized [OPG study]4.9411739
GSM549135patient 035, cancer, homogenized [OPG study]4.8859639